CareDx (CDNA) Misses Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to CareDx (CDNA) Misses Q1 EPS by 8c
May 5, 2022 4:01 PM EDT
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today reported financial results for the first quarter ended March 31, 2022.
Recent Highlights:
Achieved total revenue of $79.4 million for the three months ended March 31, 2022, increasing 18% year-over-yearProvided approximately 42,600 AlloSure and AlloMap patient results in the quarter, with March being our highest ever month of testing volume for Heart and Kidney Testing...
More
May 5, 2022 4:01 PM EDT
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today reported financial results for the first quarter ended March 31, 2022.
Recent Highlights:
Achieved total revenue of $79.4 million for the three months ended March 31, 2022, increasing 18% year-over-yearProvided approximately 42,600 AlloSure and AlloMap patient results in the quarter, with March being our highest ever month of testing volume for Heart and Kidney...
More
